Prothena | PRTA - Trade Creditors


Prothena reported $1.69M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 16.33M 28.24M Sep/2026
Agios Pharmaceuticals USD 19.93M 3.58M Sep/2026
Akebia Therapeutics USD 7.61M 1.81M Sep/2026
ALKERMES USD 107.69M 35.17M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Amgen USD 20.83B 17.97B Sep/2026
Biogen USD 430.3M 26.4M Sep/2026
BioMarin Pharmaceutical USD 946.11M 32.44M Sep/2026
Exelixis USD 30.83M 8.23M Sep/2026
Immunic USD 11.01M 873K Mar/2026
Incyte USD 235.37M 1.16B Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
MacroGenics USD 3.14M 300K Sep/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 754.1M 612.1M Sep/2026
Prothena USD 1.69M 249K Sep/2026
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Ultragenyx Pharmaceutical USD 45M 6M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026